Hematology
Conference Coverage
Idarucizumab reverses dabigatran’s anticoagulant effects
Key clinical point: The investigational monoclonal antibody idarucizumab reversed the anticoagulant effects of dabigatran. Major finding:...
Commentary
MRSA coverage in cellulitis treatment
Should cellulitis treatment always include an antibiotic that covers MRSA?
News
FDA: SGLT2 inhibitors may lead to ketoacidosis
News
New guidelines address hypopituitarism in TBI
Key clinical point: Screening for and treating pituitary hormone deficiencies is recommended for people with complicated mild traumatic brain...
News
More than 75% with sickle cell crises don’t get hydroxyurea
Key clinical point: More than 75% of adults with sickle cell anemia who have frequent pain crises fail to get hydroxyurea therapy as recommended....
News
Unrecognized diabetes common in acute MI
Key clinical point: Many patients presenting with acute MI had unrecognized diabetes and, in most cases, that DM remained undiagnosed, untreated,...
News
Extended anticoagulant therapy reduced risk of VTE recurrence
News
Lentiviral gene therapy could prove useful for adults with hemophilia
Government and Regulations
FDA: Limit testosterone use to men with specific medical conditions
News
Stroke thrombolysis achieved inside an hour works best
Key clinical point: Acute ischemic stroke patients who started intravenous tPA within an hour of onset had the best outcomes. Major finding:...
News
Faster intra-arterial stroke treatment improved outcomes
Key clinical point: A delayed start to intra-arterial treatment of acute ischemic stroke blunted its benefit. Major finding: For every 1-hour...